Predicting Metabolic Syndrome Using Decision Tree and Support Vector Machine Methods

Overview

Journal ARYA Atheroscler

Date 2016 Oct 19

PMID 27752272

Citations 23

Authors

Farzaneh Karimi-Alavijeh

Saeed Jalili

Masoumeh Sadeghi

Affiliations

Soon will be listed here.

Abstract

Background: Metabolic syndrome which underlies the increased prevalence of cardiovascular disease and Type 2 diabetes is considered as a group of metabolic abnormalities including central obesity, hypertriglyceridemia, glucose intolerance, hypertension, and dyslipidemia. Recently, artificial intelligence based health-care systems are highly regarded because of its success in diagnosis, prediction, and choice of treatment. This study employs machine learning technics for predict the metabolic syndrome.

Methods: This study aims to employ decision tree and support vector machine (SVM) to predict the 7-year incidence of metabolic syndrome. This research is a practical one in which data from 2107 participants of Isfahan Cohort Study has been utilized. The subjects without metabolic syndrome according to the ATPIII criteria were selected. The features that have been used in this data set include: gender, age, weight, body mass index, waist circumference, waist-to-hip ratio, hip circumference, physical activity, smoking, hypertension, antihypertensive medication use, systolic blood pressure (BP), diastolic BP, fasting blood sugar, 2-hour blood glucose, triglycerides (TGs), total cholesterol, low-density lipoprotein, high density lipoprotein-cholesterol, mean corpuscular volume, and mean corpuscular hemoglobin. Metabolic syndrome was diagnosed based on ATPIII criteria and two methods of decision tree and SVM were selected to predict the metabolic syndrome. The criteria of sensitivity, specificity and accuracy were used for validation.

Results: SVM and decision tree methods were examined according to the criteria of sensitivity, specificity and accuracy. Sensitivity, specificity and accuracy were 0.774 (0.758), 0.74 (0.72) and 0.757 (0.739) in SVM (decision tree) method.

Conclusion: The results show that SVM method sensitivity, specificity and accuracy is more efficient than decision tree. The results of decision tree method show that the TG is the most important feature in predicting metabolic syndrome. According to this study, in cases where only the final result of the decision is regarded significant, SVM method can be used with acceptable accuracy in decision making medical issues. This method has not been implemented in the previous research.

Citing Articles

Prediction of metabolic syndrome using machine learning approaches based on genetic and nutritional factors: a 14-year prospective-based cohort study.

Shin D BMC Med Genomics. 2024; 17(1):224.

PMID: 39232768 PMC: 11373243. DOI: 10.1186/s12920-024-01998-1.

Predicting dyslipidemia incidence: unleashing machine learning algorithms on Lifestyle Promotion Project data.

Naderian S, Nikniaz Z, Farhangi M, Nikniaz L, Sama-Soltani T, Rostami P BMC Public Health. 2024; 24(1):1777.

PMID: 38961394 PMC: 11223414. DOI: 10.1186/s12889-024-19261-8.

The effect of data balancing approaches on the prediction of metabolic syndrome using non-invasive parameters based on random forest.

Mohseni-Takalloo S, Mohseni H, Mozaffari-Khosravi H, Mirzaei M, Hosseinzadeh M BMC Bioinformatics. 2024; 25(1):18.

PMID: 38212697 PMC: 10782700. DOI: 10.1186/s12859-024-05633-9.

Employing broad learning and non-invasive risk factor to improve the early diagnosis of metabolic syndrome.

Duan J, Wang Y, Chen L, Chen C, Zhang R iScience. 2024; 27(1):108644.

PMID: 38188510 PMC: 10770709. DOI: 10.1016/j.isci.2023.108644.

Metabolic syndrome prediction model using Bayesian optimization and XGBoost based on traditional Chinese medicine features.

Zheng J, Zhang Z, Wang J, Zhao R, Liu S, Yang G Heliyon. 2023; 9(12):e22727.

PMID: 38125549 PMC: 10730568. DOI: 10.1016/j.heliyon.2023.e22727.

References

Gomez-Ruiz J, Ramos-Jimenez G, Munoz-Perez J, Alba-Conejo E . A combined neural network and decision trees model for prognosis of breast cancer relapse. Artif Intell Med. 2002; 27(1):45-63. DOI: 10.1016/s0933-3657(02)00086-6. View

Liu H, Zhang R, Luan F, Yao X, Liu M, Hu Z . Diagnosing breast cancer based on support vector machines. J Chem Inf Comput Sci. 2003; 43(3):900-7. DOI: 10.1021/ci0256438. View

Hirose H, Takayama T, Hozawa S, Hibi T, Saito I . Prediction of metabolic syndrome using artificial neural network system based on clinical data including insulin resistance index and serum adiponectin. Comput Biol Med. 2011; 41(11):1051-6. DOI: 10.1016/j.compbiomed.2011.09.005. View

Furey T, Cristianini N, Duffy N, Bednarski D, Schummer M, Haussler D . Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics. 2000; 16(10):906-14. DOI: 10.1093/bioinformatics/16.10.906. View

Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N . The Isfahan cohort study: rationale, methods and main findings. J Hum Hypertens. 2010; 25(9):545-53. DOI: 10.1038/jhh.2010.99. View

Khan J, Wei J, Ringner M, Saal L, Ladanyi M, Westermann F . Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med. 2001; 7(6):673-9. PMC: 1282521. DOI: 10.1038/89044. View

Esteghamati A, Ashraf H, Rashidi A, Meysamie A . Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract. 2008; 82(1):104-7. DOI: 10.1016/j.diabres.2008.07.009. View

Worachartcheewan A, Nantasenamat C, Isarankura-Na-Ayudhya C, Pidetcha P, Prachayasittikul V . Identification of metabolic syndrome using decision tree analysis. Diabetes Res Clin Pract. 2010; 90(1):e15-8. DOI: 10.1016/j.diabres.2010.06.009. View

Yu Y, Chen S, Wang L, Chen W, Guo W, Yan H . Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology. 2005; 68(1):79-86. DOI: 10.1159/000084824. View

10.

Zabetian A, Hadaegh F, Azizi F . Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007; 77(2):251-7. DOI: 10.1016/j.diabres.2006.12.001. View

11.

Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17):2735-52. DOI: 10.1161/CIRCULATIONAHA.105.169404. View

12.

Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, Neil Thomas G . Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med. 2013; 16(3):138-44. DOI: 013163/AIM.004. View

13.

Yu W, Liu T, Valdez R, Gwinn M, Khoury M . Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak. 2010; 10:16. PMC: 2850872. DOI: 10.1186/1472-6947-10-16. View

14.

Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A . Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010; 13(3):243-4. View

15.

Lemieux I, Poirier P, Bergeron J, Almeras N, Lamarche B, Cantin B . Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?. Can J Cardiol. 2007; 23 Suppl B:23B-31B. PMC: 2794461. DOI: 10.1016/s0828-282x(07)71007-3. View

16.

Doniger S, Hofmann T, Yeh J . Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms. J Comput Biol. 2003; 9(6):849-64. DOI: 10.1089/10665270260518317. View